Detailed entry information

Protein Information (annotations from UniProt)

Database IDHIV0001088
UniProt IDQ9H479
Primary gene name(s)FN3K
Synonym gene name(s)unknown
Protein nameFructosamine-3-kinase
Protein functionMay initiate a process leading to the deglycation of fructoselysine and of glycated proteins. May play a role in the phosphorylation of 1-deoxy-1-morpholinofructose, DMF, fructoselysine, fructoseglycine, fructose and glycated lysozyme.
Subcellular locationunknown
ECO codeClick here for more information.
Amino acid sequence
FASTA format: Q9H479
Gene Ontology
(Biological Process)
Complete annatation
epithelial cell differentiation [GO:0030855];
fructosamine metabolic process [GO:0030389];
fructoselysine metabolic process [GO:0030393];
post-translational protein modification [GO:0043687]
Gene Ontology
(Molecular Function)
Complete annatation
fructosamine-3-kinase activity [GO:0030387];
kinase activity [GO:0016301]
Gene Ontology
(Cellular Component)
Complete annatation
cytosol [GO:0005829]
Protein-protein interaction122075
Phylogenetic treeQ9H479
HIV replication factor status Zhou et al., Cell. Host. Microbe., 2008
Brass et al., Science, 2008
Smith et al., J. Immunol, 2010
gene status
Lu et al., J. Virol., 2011
      Folds changes 8h: unknown; Folds changes 16h: unknown; Tested: unknown;
Schoggins JW and Rice CM, Curr. Opin. Virol., 2011
      Targeted viruses: unknown
      Viral life cycle: unknown
      Mechanism related to antiviral activity: unknown
Anti-viral restriction factor Liu et al., Retrovirology, 2011
      unknown (Triplicates)

Gene Expression Profile       top

            Up-regulated;            Down-regulated

For brief introduction to each study, please go to the help page.

Gene expression during HIV latency

(1). Mohammadi et al., PLoS Pathog., 2014

Differentially expressed transcripts (Pairwise) during latency and subsequent viral reactivation using several agents - Primary CD4+ T-cell based model

DMSO: Dimethyl suloxyde (negative control) - 0.0033% final
SAHA: Vorinostat (Histone deacetylase inhibitor) - 0.5 μM
CD3: TCR Stimulation by IL-2+ antiCD3/anti-CD28 antibodies
IL7: Interleukin-7 based stimulation
DISU: Disulfiram (alcohol dehydrogenase inhibitor) - 0.5 μM
AZA: 5-azacytidine (AZA; DNA methylation inhibitor) - 1 μM
Experimental Condition Log2 Fold Change P value Adjusted P value
AZA vs. CD3-1.45752029386520.0001345029898720540.000628403305440669
AZA vs. DISU0.3534677734910650.2206319107539320.810317462818746
AZA vs. IL7-0.09782008880717310.737623495380610.999311006273513
AZA vs. SAHA-0.1455150811673770.7497294464257430.931550365621333
DISU vs. CD31.799152061515371.01090401168902e-057.54425884863858e-05
DISU vs. IL7-0.4621344585400460.1056333149551060.427199793530442
DISU vs. SAHA-0.4955872733791780.2300521320153460.607913172071483
DMSO vs. AZA0.1519412822256590.6024310630670181
DMSO vs. CD31.596955540747631.63199942148085e-058.94364179141831e-05
DMSO vs. DISU-0.2041247469875530.4592760143806380.892292895476476
DMSO vs. IL7-0.2400126427334720.3733083974216150.831458117840584
DMSO vs. SAHA-0.3013126849267480.4928459689711640.809909671613173
HIV vs. Mock in Activationunknownunknownunknown
HIV vs. Mock in Latency0.3891981288414460.0526148968080150.901269266459112
IL7 vs. CD31.361027445637230.0002647375130420130.00135221570114614
SAHA vs. CD31.28816526588040.004299794625879370.0125431484730937
SAHA vs. IL7-0.04858958566668360.9128493959448080.966891031836218
(2). Iglesias-Ussel et al., J. Virol., 2013

Up and Downregulated transcripts during Latency (Latently infected CD4+ T cells vs Uninfected)- Primary CD4+Tcell based model
Log2 Fold Change P Value
unknown unknown

Gene expression during HIV infection and replication

(1). Imbeault et al., PloS Pathog., 2012

Transcriptomic profiling of HIV-1 infected CD4+ T cells - Primary CD4+ T cells
Experiment type Log2 Fold Change P Value Adjusted P Value
Infected vs. Mock unknown unknown unknown
Infected vs. Bystander unknown unknown unknown
(2). Lefebvre et al., J. Virol., 2011

Transcriptome analysis of T-cell line (Sup T1)
Log2 Fold Change unknown
(3). Li et al., J. Immunol., 2013

Lymphatic tissue
Acute Fold Change Acute P Value Asymt Fold Change Asypt P Value AIDS Fold Change AIDS P Value
unknown unknown unknown unknown unknown unknown
(4). Chang et al., MBio., 2011

Transcriptome analysis of T-cell line (Sup T1)

Derived from Sherrill-Mix et al., BMC Retrovirol., 2015 cross validation
Up-regulated (True) TRUE
(5). Sherrill-Mix et al., BMC Retrovirol., 2015

Deep RNA-seq analysis of primary human T cell infected with low passage HIV isolate HIV89.6 - Primary CD4+ T cell based
Test Status Log2 Fold Change P Value
OK -0.339603 0.142749
(6). Rotger et al., PLoS Pathog., 2010

Genome-wide mRNA expression of CD4+ T cells from HIV-infected patient
(Genes differentially expressed (at adjusted p<0.01) according to the empirical Bayes approach)
Log2 Fold Change P Value
unknown unknown

Proteomic/Transcriptomics studies indicating differentially expressed genes mediated by HIV

(1). Greenwood et al., Elife, 2016

Activated (CD3/CD28) Primary human CD4+ T cells infected with pNL4-3-dE-EGFP. The table shows the complete (unfiltered) TMT (tandem mass tag)-based proteomic time course dataset
6 h 24 h 48 h 72 h RTi
unknown unknown unknown unknown unknown
(2). Navare et al., Virology, 2012

SUP-T1 cell line
FC-4hpi P-value FC-8hpi P-value FC-20hpi P-value Category
unknown unknown unknown unknown unknown unknown unknown
(3). Hyrcza et al., J. Virolo., 2007

Primary human CD4+ and CD8+ T Cells
Affymetrix Prob ID Fold Change In CD8? Category
unknown unknown unknown unknown

Protein Overview       top

Drug-protein Interaction       (annotations from DrugBank)      top

not found

Protein Secondary Structure       (annotations from PDB)      top

not found

HIV-1 Interaction       (annotations from NCBI HIV-1 Interaction Database)      top

not found

Metabolic/Signalling Pathway       (annotations from KEGG database)      top

Pathway Accession Number Description
not found